Mobile health startup Gauss Surgical has raised $1.5 million through the sale of equity as part of a total offering that could reach more than $2 million, according to a filing with the SEC.
The Silicon Valley company recently received FDA approval for its Triton Fluid Management System. The Triton app uses an iPad camera that scans surgical gauze as a way of seeing in real time what a patient’s blood loss is during surgery. The images are then sent to the cloud and into an algorithm that can help inform surgeons when or if a blood transfusion is necessary.
The traditional method for gauging blood loss in surgery has been to weigh surgical sponges and the surgeon’s best estimation.
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Gauss was founded in 2011 and is headed by CEO Milton McColl and co-founder Siddarth Satish.